Key figures
- Revenue: $546.0 million (prior period: $523.8 million; up 4.2%)
- Result: net profit after tax attributable to shareholders of $20.4 million (prior period: net profit after tax attributable to shareholders of $16.0 million; up 27.7%)
- Operating profit before interest and tax: $45.3 million (prior period: $38.7 million; up 16.9%)
- Profit before tax: $35.8 million (prior period: $28.8 million; up 24.2%)
- Basic earnings per share: 14.19 cents per share (prior period: 11.13 cents per share)
- Dividend: final dividend of 5.5 cents per share
FY2026 results
Operating revenue was $546.0 million. Operating profit before interest and tax was $45.3 million and Profit before tax was $35.8 million. The company declared a final dividend of 5.5 cents per share.
Compared with the prior period
Revenue was $546.0 million, up 4.2% on $523.8 million in the prior period. The statutory result was a net profit after tax attributable to shareholders of $20.4 million, up 27.7% on a net profit after tax attributable to shareholders of $16.0 million in the prior period. Operating profit before interest and tax was $45.3 million, up 16.9% on $38.7 million in the prior period.
In the company's words
Investment in technology, targeted refurbishments and cost management will be priorities in both divisions.
---
Source: Green Cross Health Limited, "Green Cross Health Full Year Results to 31 March 2026" (28 May 2026), https://www.nzx.com/announcements/473534.
Updated 24 October 2026: rewritten so that every figure is taken directly from the company's announcement. Earlier versions of these automated articles contained errors. This article was generated from the company's NZX results announcement by NZXplorer's automated reporting system. Every figure is taken from that announcement. It is provided for information only and is not financial advice.